Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Consider benefits and risks of new alopecia treatments for safety.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Combination therapy improves hair growth in advanced hair loss.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

HAT-L4 is crucial for preventing body fluid loss by maintaining skin barrier integrity.

FGF-2&D/P nanoparticles can help treat hair loss.

Sargassum muticum extract and its component apo-9'-fucoxanthinone may help hair growth and treat hair loss.

Finasteride slows down motherly behavior in first-time pregnant rats.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.